secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2026-06-05T10:33:22+00:00
Accession:  0000313143-26-000057
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics combines Plasma and Blood Center segments into Apheresis; Hospital renamed MedSurg
--------------------------------------------------------------------------------

- The new Apheresis segment combines formerly separate Plasma and Blood Center segments, effective Q1 FY2027.
- Hospital segment renamed MedSurg to better reflect underlying businesses, technologies, and markets.
- Supplemental presentation includes historical quarterly reconciliations from Q1 FY2024 to Q4 FY2026.
- FY2027 guidance recast under new segment structure; company not reaffirming or updating guidance.
- Updates, if any, to be provided on Q1 FY2027 earnings call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314326000057/0000313143-26-000057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314326000057/hae-20260605.htm
  HTML page:      https://secwatch.observer/filing/0000313143-26-000057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer